Chronic graft-versus-host disease (cGVHD) is a serious complication that can occur after allogeneic hematopoietic stem cell transplantation. It arises when donor immune cells attack the recipient's tissues, leading to a range of symptoms affecting the skin, liver, gastrointestinal tract, and other organs. Accurate coding with ICD-10 Code D89.811 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code D89.811 specifically denotes chronic graft-versus-host disease, a condition that typically develops after stem cell or bone marrow transplants. This code is used when documenting the diagnosis in clinical settings, particularly when patients exhibit symptoms related to the immune response against host tissues. It is crucial for accurate billing and tracking of complications associated with transplant procedures.
Chronic graft-versus-host disease is primarily caused by the immune response of donor T cells against the recipient's tissues following transplantation. The condition can progress over time, leading to significant morbidity and requiring prompt medical intervention. Early recognition and management are vital to improve patient outcomes.
ICD-10 Code D89.811 is utilized in SOAP notes to document the presence of chronic graft-versus-host disease, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code D89.811 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of chronic graft-versus-host disease. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Chronic graft-versus-host disease often necessitates hospitalization for intensive management. Treatment strategies focus on immunosuppression and supportive care to mitigate symptoms and prevent complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D89.811 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99214 | Established patient office visit, moderate complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
| 96413 | Chemotherapy administration, intravenous, push technique. |
Common Questions About Using ICD-10 Code D89.811 for Chronic graft-versus-host disease
What are the common symptoms of chronic graft-versus-host disease?
Common symptoms include skin rashes, gastrointestinal issues like diarrhea, liver dysfunction, and respiratory problems. Patients may also experience fatigue and weight loss due to the systemic effects of the disease.
How is chronic graft-versus-host disease diagnosed?
Diagnosis is typically based on clinical evaluation, patient history, and laboratory tests. Skin biopsies and liver function tests may also be utilized to confirm the diagnosis and assess severity.
What treatments are available for chronic graft-versus-host disease?
Treatment often involves immunosuppressive therapies such as corticosteroids and calcineurin inhibitors. Supportive care is also crucial for managing symptoms and preventing complications.
Is chronic graft-versus-host disease contagious?
No, chronic graft-versus-host disease is not contagious. It is an immune-mediated condition that occurs following transplantation and is not transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes